Browsing by Author "Siamopoulos, K. C."
Now showing items 1-6 of 6
-
Article
The beneficial effect of tamoxifen on serum lipoprotein-a levels: An additional anti-atherogenic property
Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Fountzilas, George; Tzallas, C. S.; Siamopoulos, K. C.; Tsolas, O.; Pavlidis, Nicholas (1996)It has recently been suggested that increased lipoprotein (a) levels are an independent risk factor for coronary heart disease. It has also been reported that tamoxifen can induce changes in blood lipid values. In this ...
-
Article
Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective study
Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Fountzilas, George; Tzallas, C. S.; Tsolas, O.; Siamopoulos, K. C.; Pavlidis, Nicholas (1998)Background and Aim: As a continuation of our investigational program we carried out the present study to evaluate and compare the impact of LH-RH analogues and tamoxifen on serum lipid parameters in premenopausal women ...
-
Article
The natural course of primary Sjögren's syndrome (a clinical study)
Pavlidis, Nicholas; Drosos, Alexandros A.; Galanopoulos, V.; Siamopoulos, K. C.; Tsianos, Epameinondas (1988)In this work the authors analyzed the clinical course and diagnostic procedures of 104 patients with primary Sjogren's syndrome (pSS): 57 patients diagnosed and followed-up at Ioannina University and 47 similar patients ...
-
Article
New evidence that tamoxifen does not induce osteoporosis: A nuclear activation analysis and absorptiometry study
Kalef-Ezra, J. A.; Glaros, D.; Klouvas, G. D.; Hatzikonstantinou, I.; Karantanas, A. H.; Siamopoulos, K. C.; Pavlidis, Nicholas (1992)The possibility of increased risk for osteoporosis in breast cancer patients treated with tamoxifen was investigated. 26 patients aged 41-65 years without skeletal metastases were studied. All patients were treated with ...
-
Article
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Briassoulis, E. Ch; Judson, Ian Robert; Pavlidis, Nicholas; Beale, P.; Wanders, J.; Groot, Y.; Veerman, G.; Schuessler, M.; Niebch, G.; Siamopoulos, K. C.; Tzamakou, E.; Rammou, D.; Wolf, L.; Walker, R.; Hanauske, A. R. (2000)Purpose: To determine the maximum-tolerated dose (MTD), the principal toxicities, and the pharmacokinetics of 6-hour infusion of glufosfamide (beta-D-glucosylisophosphoramide mustard; D-19575), a novel alkylating agent ...
-
Article
Serum anion gap in multiple myeloma patients
Elisaf, Moses S.; Siamopoulos, K. C.; Bourantas, C. L.; Papagalanis, N.; Pavlidis, Nicholas (1992)The aim of this study was, first, to reconfirm the low serum anion gap (SAG) in multiple myeloma patients and, second, to propose the possible pathophysiologic mechanisms involved. We studied 20 patients with IgG multiple ...